<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Billeter, A.T.* et al. Gastric bypass resolves metabolic dysfunction-associated fatty liver disease (MAFLD) in low-BMI patients: A prospective cohort study. Ann. Surg. 276, 814-821 (2022)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=65745&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=65745&amp;la=de</guid>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Becker, K.* et al. Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Ann. Surg. 256, 1002-1007 (2012)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11644&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=11644&amp;la=de</guid>
      <pubDate>Mon, 31 Dec 2012 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Becker, K.* et al. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: A summary of 480 cases. Ann. Surg. 253, 934-939 (2011)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6052&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=6052&amp;la=de</guid>
      <pubDate>Fri, 09 Sep 2011 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>